Evaluation of Serum Levels of Zinc, Copper, Iron, and Zinc/Copper Ratio in Cutaneous Leishmaniasis
-
F Pourfallah
,
S Javadian
,
Z Zamani
,
R Saghiri
,
S Sadeghi
,
B Zarea
,
Sh Faiaz
,
F Mirkhani
,
N Fatemi
Abstract
Background: The purpose of this study was to evaluate the levels of zinc (Zn), copper (Cu), iron (Fe) and zinc/ copper ratio in the serum of patients with cutaneous leishmaniasis in Qom Province, center of Iran.
Methods: Serum levels of zinc and copper were determined by flame atomic absorption spectrophotometer and serum iron concentration was measured by using an Auto Analyzer. The study group consisted of 60 patients with cutaneous leishmaniasis and the control group of 100 healthy volunteers from the same area who were not exposed to cutaneous leishmaniasis.
Result: There were no statistically significant differences in age and body mass index between the two groups. Serum Zn (P< 0.001) and Fe (P< 0.05) levels were lower in patients with cutaneous leishmaniasis than the control group. We also found serum Cu concentration (P< 0.05) in the patient group was significantly higher than that of the control group. However, zinc/ copper ratio (P< 0.001) was lower in patients with cutaneous leishmaniasis than in the control group.
Conclusion: Our data indicated that Zn/Cu ratio was significantly lower in patients with CL as compared to the controls. Earlier reports suggest that, this ratio imbalance could be a useful marker for immune dysfunction in leishmaniasis. There was also strong association of Zn, Cu and Fe with CL. It suggests the use of blood zinc, copper, iron concentration and the copper/zinc ratio (Zn/Cu), as a means for estimating the prognosis of CL.
Barber EF, Cousins RJ (1988) Interleukin-1 stimulated induction of ceruloplasmin syn- thesis in normal and copper-deficient rats. J Nutr. 118: 375–381.
Barollo R, D'Inc M, ScarpaV, et al. (2005) Effects of iron manipulation on trace ele- ments level in a model of colitis in rats. World J Gastroenterol. 11(28): 4396-399.
Cillarie E, Dieli M, Maltese E, et al. (1989) Enhancement of macrophage IL-1 pro- duction by Leishmania major infection in vitro and its inhibition by IFN. J Im- munol .143(6): 2001-2005.
Cousins RJ (1985) Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev. 65: 238-241. Desjeux P (1996) Cutaneous leishmaniasis:public health aspects and control. Clin Dermatol. 14: 417-423.
Faryadi M, Mohebali M (2003) Alterations of serum zinc, copper and iron con- centrations in patients with acute and chronic cutaneous leishmaniasis. Ira- nian J Publ Health. 32 (4): 53-58.
Khatami A, Firooz A, Gorouhi F, et al. (2005) Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials. Journal of the American Acad- emy of Dermatology. 57(2): 335-340.
Klassing KC, Laurin DE, Penk RK, et al. (1987) Immunological mediated growth depression in chicks: influence of feed intake, corticosterone and interleukin1. J Nutr. 117: 1629- 1637.
Kirgbright GF (1980) Atomic absorption spec- troscopy, Elemental analysis of biological materials. Vienna Technical Report Se- ries. Int Atomic Agency. 197: 141-165.
Kocyigit O, Erel MS, Gurel S, et al. (1998) Alterations of serum selenium, zinc, cop- per and iron concentrations, and some related antioxidant enzyme activities in patients with cutaneous leishmaniasis. Biol Trace Element Res. 65: 271–281.
Kocyigit A, Gur S, Erel O, et al. (2002) As- sociations among plasma selenium, zinc, copper, and iron concentrations and im- munoregulatory cytokine levels in pa- tients with cutaneous leishmaniasis. Biol Trace Elem Res. 90: 47-55.
Liew FY, Parkinson C, Millott S, et al. (1990) Tumor necrosis factor (TNF-α) in leishmaniasis. TNF-α mediates host- protection against cutaneous leishma- niasis. Immunology. 69(4): 570-73.
Lin M, Rippe RA, Niemela O, et al. (1997) Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol.272: 1355-1364.
Mertz W (1988) The essential trace elements.Science. 213: 1332-1338.
Najim RA (1998) Zinc sulfate in the treat- ment of cutaneous leishmaniasis: an in vitro and animal study. Mem Inst Os- waldo Cruz. 93: 831-833.
Panemangalore M, Bebe FN (1996) Effect of high dietary zinc of plasma ceruloplas- min and erythrocyte superoxide dismu- tase activities in copper-depleted and re- pleted rats. Biol Trace Elem Res. 55(1-2):111-26.
Peralta V, Cuesta MJ, Mata I,et al. (1999) Serum iron in catatonic and noncata- tonic psychotic patients. Biol Psych.45(6): 788-90.
Rofe AM, Philcox JC, Coyle P (1996) Trace metal, acute phase and metabolic re- sponse to endotoxin in metallothionein- null mice. Biochem J. 314: 793-797.
Shanker AH, Parasad AS (1998) Zinc and immune function: the biological basis of altered resistance to infection. AJ Nutr. 68 (suppl): 447S-63S.
Sharquie KB (2001) Oral zinc sulfate in the treatment of acute cutaneous leishma- niasis. Clin Exp Dermatol. 26: 21-26.
Soleimani M (2003) Oral zinc sulfate in the treatment of acute cutaneous leishma- niasis. Iranian Journal of Dermatology.2: 20-24 (In Persian).
Sprietsma JE (1999) Zinc-controlled Th1/Th2 switch significantly determines devel- opment of diseases. Med Hypotheses.49: 1-14.
Svenson KLG, Hallgren R, Johansson E, Lindh U (1985) Reduced zinc in pe- ripheral blood cells from patients with inflammatory connective tissue dis- ease. Inflammation. 9(2): 189-199.
Tudor R, Zalewski PD, Ratnaike RN (2005) Zinc in health and chronic disease. J Nutr Health Aging. 9(1): 45-51.
Weyenbergh V, Santana G, D'Oliveira A, et al. (2004) Zinc/copper imbalance re- flects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study. BMC Infect Dis 4: 50-59.
| Files | ||
| Issue | Vol 3 No 2 (2009) | |
| Section | Articles | |
| Keywords | ||
| Cutaneous leishmaniasis Zn Cu Fe. Zn/Cu ratio Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
